[Therapeutic effect of Ciba 13437-Su in 40 patients with familial essential hyperlipemia].
D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D000787:Angina Pectoris / Q000188:drug therapy; D000790:Angiocardiography; D001219:Aspartate Aminotransferases / Q000097:blood; D001706:Biopsy; D001786:Blood Glucose; D001797:Blood Protein Electrophoresis; D001835:Body Weight; D002784:Cholesterol / Q000097:blood*; D017023:Coronary Angiography; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000235:genetics*; D007383:Intermittent Claudication / Q000188:drug therapy; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood*; D008099:Liver / Q000473:pathology; D008297:Male; D008854:Microscopy, Electron; D008875:Middle Aged; D009281:Naphthalenes / Q000009:adverse effects / Q000627:therapeutic use*; D010636:Phenols / Q000627:therapeutic use; D011422:Propionates / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood; D014973:Xanthomatosis / Q000188:drug therapy*
D001786:Blood Glucose; D008055:Lipids; D008074:Lipoproteins; D009281:Naphthalenes; D010636:Phenols; D011422:Propionates; D014280:Triglycerides; D002784:Cholesterol; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase
Therapeutische Wirkung von Ciba 13 437-Su bei 40 Patienten mit familiärer essentieller Hyperlipidämie.